Skip to content
M&A comeback may face political headwinds, say BIO CEO panelists
When it comes to biotech M&A, 2024 wasn’t a great year, but it ...
Read More
BIO promotes its partnership with farmers and ranchers at Farm Bureau Convention
As farmers, ranchers, and biotech companies work together to keep America strong and ...
Read More
BIO coffee chat focuses on reimbursement for Accelerated Approval Pathway drugs
The U.S. Food and Drug Administration’s Accelerated Approval Pathway enables the timely development ...
Read More
BIO CEO 2025: Challenges and opportunities in the new administration
Seeking biotech-friendly policy from the new administration and Congress will be daunting and ...
Read More
BIO CEO 2025: New solution for the challenge of schizophrenia
Despite a pressing demand, schizophrenia has had limited treatment. “Roughly 1% of the ...
Read More
BIO CEO 2025: AI is a tool – not magic
The idea of AI supercharging drug development is stirring a lot of excitement. ...
Read More
EDITORS' CHOICE
What BIO’s watching in the new Congress
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top priorities ...
Read More
LATEST NEWS
BIO Events
M&A comeback may face political headwinds, say BIO CEO panelists
When it comes to biotech M&A, 2024 wasn’t a great year, but it wasn’t “horrible,” according to analysts at the BIO CEO & Investor Conference ...
Agriculture
BIO promotes its partnership with farmers and ranchers at Farm Bureau Convention
As farmers, ranchers, and biotech companies work together to keep America strong and well-fed, they need supportive policy, an expert from the Biotechnology Innovation Organization ...
BIO Events
BIO coffee chat focuses on reimbursement for Accelerated Approval Pathway drugs
The U.S. Food and Drug Administration’s Accelerated Approval Pathway enables the timely development of treatments for severely ill patients who have few if any other ...
BIO Events
BIO CEO 2025: Challenges and opportunities in the new administration
Seeking biotech-friendly policy from the new administration and Congress will be daunting and perhaps confusing, but there are still a lot of potential wins to ...
BIO Events
BIO CEO 2025: New solution for the challenge of schizophrenia
Despite a pressing demand, schizophrenia has had limited treatment. “Roughly 1% of the entire world population has schizophrenia,” said Boobalan Pachaiyappan, Managing Director and Senior ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
John Crowley highlights Colorado’s biotech ecosystem during packed Denver tour
Colorado’s contributions to biotechnology innovation—and biotech’s importance to our health, food supply, and national security—were key themes as BIO President ...
Read More
International
Bio's View
What the Hims & Hers Super Bowl commercial gets wrong about innovation… and America
“This is America,” goes the musical refrain of the new Hims & Hers Super Bowl ad for its compounded obesity ...
Read More
